[PDF] Top 20 La didáctica: un escenario para la construcción de juegos de lenguaje

... the pleural effusion revealed pleural dissemi- ...the pleural effusion was ER-positive, she was diagnosed with a recurrence of her right breast ...citrate. After initiation of ... See full document

... cm) and received a modified radical mastecto- my in 2010-3-21, Pathological examination of the tumor revealed an invasive duct carcinoma, stage II (T2N0M0). There was no lympho-vascu- lar invasion and all 7 ... See full document

... double cancer of the esophagus and breast is rare, and axillary lymph node metastasis (ALM) in esophageal cancer is also very ...We report a case of advanced ... See full document

... reducing breast cancer recurrence and on potential side effects and ways to manage these should they ...nurse cancer care review and community pharmacist ... See full document

... contralateral breast cancer in patient received tamoxifen treatment had not been re- ...a case of uterine carcinosarcoma co-occurrenced with contralateral breast cancer in a 56-year- ... See full document

... Conclusion Improving adherence to AET will reduce recurrence of and mortality from breast cancer. However, medication-taking behavior is complex and involves patient, health profes- sional, and process ... See full document

... Figure 1. MRI was performed using the 3.0-T system. A. On axial non-fat-saturated T1-weighted images, mass shows round, smooth, homogeneous, low signal intensity. B. On axial fat-saturated T2-weighted images, mass shows ... See full document

... for metastasis to develop and thus metastases arising from breast cancer are rarely ...We report a case of a 61-year-old female with two-year history of breast cancer who ... See full document

... chemo- therapy, distant recurrence was reported in 26 patients ...TEXT after a median follow-up of 8 years and 9 years, ...from breast cancer with exemestane–ovarian suppression ... See full document

... of breast cancer. Endocrine therapies targeting the ER represent one of the most successful anticancer strategies to ...established endocrine therapies to maximise ...in breast ... See full document

... primary endocrine therapy before surgical excision of breast tumors were chosen from the clinical database activity of the Catalan Institute of Oncology (ICO) Breast Cancer ...received ... See full document

... present case, the metastatic breast can- cer in the single lymph has similar features to the thyroid tumor or other metastatic ...metastatic cancer to select the optimal management and to determine ... See full document

... 5 years is now believed to be more efficacious, at least in other ...5 years of tamoxifen or no further therapy following randomization to receive chemotherapy with either CAF or ... See full document

... who underwent BLS (62%, 13 of 21; Table 1). No patients with brightly fluorescent stained tumors in the FGS group showed significant residual tumor tissues on postoperative MRI examination (Figure 1, E–H). One ... See full document

... of endocrine therapy and clinical contact or investigations ...women’s breast cancer treatment or side-effects of endocrine therapy ...follow-up after discontinuing ... See full document

... radiation therapy information in the SEER ...radiation therapy for women with breast cancer who were older than age 65 years in ...radiation therapy within 4 months of initial ... See full document

... An alternative approach has been utilized to develop the immunohistochemical (IHC) assay Mammostrat ® , with potential for implementation in routine pathology assessment of breast cancers. Combining the novel ... See full document

... new breast cancer diagnoses occur in women aged over 70 years in the UK ...standard breast cancer therapies may decrease [3] and older patients may prioritise quality of life over ... See full document

... Breast cancer is the most common malignancy in women. Surgery is the mainstay of ...or breast preservation in addition to axillary lymph node dissection are common surgical procedures in ... See full document

... 2012 Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast[r] ... See full document